Precision Medicine Advances in Thyroid Cancer: Translating Clinical Evidence into Practice
Chair: Laura Fugazzola
Speakers: Lori Wirth and Rossella Elisei
With the continued discovery of new genomic targets in thyroid cancer, keeping up to date with the latest advances in targeted therapy can be challenging. In this interactive symposium and case-based panel discussion, world-renowned experts will discuss recent advances in molecular testing and targeted treatments for advanced thyroid cancer and contextualize how these advances can be translated into clinical practice using real-life cases.
This symposium has been funded by a grant for Independent Medical Education provided by Lilly. The Company has had no input to the content.